Pursuant to Regulation 47 of SEBI Listing Regulations, 2015 enclosed herewith copies of the Newspaper publications providing Audited Financial Results for the Quarter ended June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venmax Drugs and Pharmaceuticals has submitted copies of newspaper advertisements that published its audited financial results for the quarter ended June 30, 2025. The results were published in 'Financial Express' (English) and 'Nava Telangana' (Telugu) on July 24, 2025, and the same is also available on the company's website www.venmaxdrugs.com. This filing is being made to comply with Regulation 47 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, which mandates that listed companies publish their quarterly financial results in newspapers. The signed letter is from Whole Time Director Venkata Rao Sadhanala. The actual financial figures in the newspaper clippings appear garbled/unreadable in the scanned document.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply fulfils the mandatory newspaper publication requirement for quarterly results under SEBI rules.